Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid and Monocytic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01076569
What this trial is testing

Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia

Who this might be right for
Childhood Acute Basophilic LeukemiaChildhood Acute Eosinophilic LeukemiaChildhood Acute Erythroleukemia (M6)+9 more
Children's Oncology Group 250
Early research (Phase 1)Study completedNCT00258271
What this trial is testing

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Rochester 18
Large-scale testing (Phase 3)UnknownNCT00454168
What this trial is testing

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Leukemia
The Vaccine Company 244
Testing effectiveness (Phase 2)Ended earlyNCT04526288
What this trial is testing

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
Fred Hutchinson Cancer Center 1
Early research (Phase 1)Ended earlyNCT04196010
What this trial is testing

Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms

Who this might be right for
Myeloid NeoplasmRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
University of Washington 13
Testing effectiveness (Phase 2)Ended earlyNCT02029417
What this trial is testing

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Roswell Park Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00005795
What this trial is testing

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Northwestern University 11
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00070135
What this trial is testing

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Alliance for Clinical Trials in Oncology 121
Early research (Phase 1)Ended earlyNCT00156299
What this trial is testing

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 15
Testing effectiveness (Phase 2)Ended earlyNCT01342887
What this trial is testing

Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Fred Hutchinson Cancer Center 6
Early research (Phase 1)Ended earlyNCT01260714
What this trial is testing

Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Ended earlyNCT01904643
What this trial is testing

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University 17
Large-scale testing (Phase 3)Study completedNCT00002798
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Childhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 880
Not applicableStudy completedNCT01338974
What this trial is testing

S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 290
Testing effectiveness (Phase 2)WithdrawnNCT00003405
What this trial is testing

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Rush University Medical Center
Early research (Phase 1)Study completedNCT01820624
What this trial is testing

Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Paolo Caimi, MD 12
Testing effectiveness (Phase 2)Study completedNCT01168219
What this trial is testing

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic Leukemia+17 more
National Cancer Institute (NCI) 68
Not applicableLooking for participantsNCT07292272
What this trial is testing

Halt Aging in Survivors of Blood Cancers

Who this might be right for
Hematological MalignancyLeukemiaLymphoid Leukemia+5 more
University of Nebraska 180
Testing effectiveness (Phase 2)Study completedNCT00795002
What this trial is testing

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
National Cancer Institute (NCI) 78
Next Page